200 related articles for article (PubMed ID: 14520514)
1. How do statins control neuroinflammation?
Adamson P; Greenwood J
Inflamm Res; 2003 Oct; 52(10):399-403. PubMed ID: 14520514
[TBL] [Abstract][Full Text] [Related]
2. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
März W; Köenig W
J Cardiovasc Risk; 2003 Jun; 10(3):169-79. PubMed ID: 12775949
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory effects of HMG-CoA reductase inhibitors.
Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
[TBL] [Abstract][Full Text] [Related]
4. Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans.
Farooqui AA; Ong WY; Horrocks LA; Chen P; Farooqui T
Brain Res Rev; 2007 Dec; 56(2):443-71. PubMed ID: 17959252
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic effects of statins and related pharmacological experimental approaches.
Alegret M; Silvestre JS
Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis.
Kuipers HF; van den Elsen PJ
Biomed Pharmacother; 2007 Aug; 61(7):400-7. PubMed ID: 17643927
[TBL] [Abstract][Full Text] [Related]
7. Potential vascular benefits of statins.
Kinlay S
Am J Med; 2005 Dec; 118 Suppl 12A():62-7. PubMed ID: 16356810
[TBL] [Abstract][Full Text] [Related]
8. Therapy insight: Potential of statins for cancer chemoprevention and therapy.
Katz MS
Nat Clin Pract Oncol; 2005 Feb; 2(2):82-9. PubMed ID: 16264880
[TBL] [Abstract][Full Text] [Related]
9. Statins alter neutrophil migration by modulating cellular Rho activity--a potential mechanism for statins-mediated pleotropic effects?
Maher BM; Dhonnchu TN; Burke JP; Soo A; Wood AE; Watson RW
J Leukoc Biol; 2009 Jan; 85(1):186-93. PubMed ID: 18840670
[TBL] [Abstract][Full Text] [Related]
10. Toward immunomodulatory and anti-inflammatory properties of statins.
Arnaud C; Braunersreuther V; Mach F
Trends Cardiovasc Med; 2005 Aug; 15(6):202-6. PubMed ID: 16182129
[TBL] [Abstract][Full Text] [Related]
11. [Anti-inflammatory effect of HMG-CoA reductase inhibitors].
Kitamoto S; Egashira K
Nihon Rinsho; 2004 Jan; 62(1):172-9. PubMed ID: 14737850
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effects of statins and autoimmune rheumatic diseases: novel intracellular mechanism involved.
Tristano AG; Fuller K
Int Immunopharmacol; 2006 Dec; 6(12):1833-46. PubMed ID: 17052674
[TBL] [Abstract][Full Text] [Related]
13. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
Robinson JG
Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
[TBL] [Abstract][Full Text] [Related]
14. HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9.
Viedt C; Shen W; Fei J; Kamimura M; Hänsch GM; Katus HA; Kreuzer J
Basic Res Cardiol; 2003 Nov; 98(6):353-61. PubMed ID: 14556080
[TBL] [Abstract][Full Text] [Related]
15. Statins: a treatment option for chronic heart failure?
von Haehling S; Okonko DO; Anker SD
Heart Fail Monit; 2004; 4(3):90-7. PubMed ID: 15772704
[TBL] [Abstract][Full Text] [Related]
16. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?
Schönbeck U; Libby P
Circulation; 2004 Jun; 109(21 Suppl 1):II18-26. PubMed ID: 15173059
[TBL] [Abstract][Full Text] [Related]
17. Statins and autoimmune diseases.
Gurevich VS; Shovman O; Slutzky L; Meroni PL; Shoenfeld Y
Autoimmun Rev; 2005 Mar; 4(3):123-9. PubMed ID: 15823497
[TBL] [Abstract][Full Text] [Related]
18. Potential therapeutic role of statins in neurological disorders.
Bifulco M; Malfitano AM; Marasco G
Expert Rev Neurother; 2008 May; 8(5):827-37. PubMed ID: 18457539
[TBL] [Abstract][Full Text] [Related]
19. The role of fat tissue in the cholesterol lowering and the pleiotropic effects of statins--statins activate the generation of metabolically more capable adipocytes.
Erol A
Med Hypotheses; 2005; 64(1):69-73. PubMed ID: 15533614
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between statins and PPARalpha in cardiovascular diseases: clinical evidence and basic mechanisms.
Paumelle R; Staels B
Trends Cardiovasc Med; 2008 Apr; 18(3):73-8. PubMed ID: 18436144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
